Physician profile
Hollan A Harper
NPI 1982074308
$40,369.65
in general payments reported to CMS, 2019-2025
7 companies · $19K in 2025
The $19K reported for 2025 was more than what 99% of Sports Medicine (Family Medicine) providers received nationally (typical 2025 total: $113).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $674 · 2022: $1,845 · 2023: $5,807 · 2024: $13K · 2025: $19K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $28K · Travel and Lodging: $7,441 · Food and Beverage: $2,810.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $27,600.00 |
| Travel and Lodging | $7,441.09 |
| Food and Beverage | $2,809.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Trice Medical, INC. | $38,321.56 | 2022-2025 | |
| Pacira Pharmaceuticals Incorporated | $1,294.04 | 2022-2025 | Iovera, Exparel, Zilretta |
| Tenex Health INC. | $658.83 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $39.26 | 2025 | |
| Kci USA, INC. | $22.41 | 2022 | |
| Heron Therapeutics, INC. | $18.04 | 2025 | Zynrelef |
| Si-Bone, INC. | $15.51 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hollan Harper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.